TickerFactsScreenerDevelopers

Arbutus Biopharma Corp (ABUS) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2013: $12.52M2014: $30.14M2015: $164.61M2016: $72.91M2017: $54.69M2018: $27.67M2019: $32.79M2020: $35.11M2021: $35.05M2022: $58.57M2023: $38.38M2024: $34.34M2025: $18.04M$18.04M
2013Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$18.04M-47.5%
2024$34.34M-10.5%
2023$38.38M-34.5%
2022$58.57M+67.1%
2021$35.05M-0.2%
2020$35.11M+7.1%
2019$32.79M+18.5%
2018$27.67M-49.4%
2017$54.69M-25.0%
2016$72.91M-55.7%
2015$164.61M+446.1%
2014$30.14M+140.7%
2013$12.52M—